Shankargouda Patil1, Saman Warnakulasuriya2,3. 1. Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, Saudi Arabia. dr.ravipatil@gmail.com. 2. Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK. 3. WHO Collaborating Centre for Oral Cancer, London, UK.
Abstract
OBJECTIVE: The aim of the present study was to systematically review the role of circulating miRNAs as potential prognostic biomarkers in head and neck cancer patients. MATERIALS AND METHODS: PubMed, EMBASE, Scopus, Web of Science, and gray literature from January 1990 up to and including September 2019 were searched. The study selection was performed by two independent reviewers according to eligibility criteria. RESULTS: A total of 13 studies that met the eligibility criteria were included. Significant number of studies were executed majorly in China and predominant number of them were case-control in nature. A total of 22 different miRNAs were found to be concomitant with very poor prognosis in cancers of the head and neck region. Of these, eighteen miRNAs (miR-375, miR-1234, miR-103, miR-638, miR-200b-3p, miR-191-5p, miR-24-3p, miR-572, miR-483-5p, miR-20a, miR-22, miR-29a, miR-29b, mir-let-7c, miR-17, miR-374b-5p, miR-425-5p, and miR-196a) were upregulated and four miRNAs (miR-9, miR-29c, miR-223, and miR-187∗) were downregulated. The hazard ratio (HR) ranged from twofold to fivefold. CONCLUSION: Based on the results, circulating miRNA may assist in the prediction of prognosis of head and neck cancer. Further multi-center randomized controlled clinical trials with large sample size are required to validate the results of the present review. CLINICAL RELEVANCE: Decoding the circulating miRNA profile could aid in accurate prognostication of head and neck cancer.
OBJECTIVE: The aim of the present study was to systematically review the role of circulating miRNAs as potential prognostic biomarkers in head and neck cancer patients. MATERIALS AND METHODS: PubMed, EMBASE, Scopus, Web of Science, and gray literature from January 1990 up to and including September 2019 were searched. The study selection was performed by two independent reviewers according to eligibility criteria. RESULTS: A total of 13 studies that met the eligibility criteria were included. Significant number of studies were executed majorly in China and predominant number of them were case-control in nature. A total of 22 different miRNAs were found to be concomitant with very poor prognosis in cancers of the head and neck region. Of these, eighteen miRNAs (miR-375, miR-1234, miR-103, miR-638, miR-200b-3p, miR-191-5p, miR-24-3p, miR-572, miR-483-5p, miR-20a, miR-22, miR-29a, miR-29b, mir-let-7c, miR-17, miR-374b-5p, miR-425-5p, and miR-196a) were upregulated and four miRNAs (miR-9, miR-29c, miR-223, and miR-187∗) were downregulated. The hazard ratio (HR) ranged from twofold to fivefold. CONCLUSION: Based on the results, circulating miRNA may assist in the prediction of prognosis of head and neck cancer. Further multi-center randomized controlled clinical trials with large sample size are required to validate the results of the present review. CLINICAL RELEVANCE: Decoding the circulating miRNA profile could aid in accurate prognostication of head and neck cancer.
Entities:
Keywords:
Blood; Head and neck cancer; Overall survival; PCR; miRNA
Authors: Patrick S Mitchell; Rachael K Parkin; Evan M Kroh; Brian R Fritz; Stacia K Wyman; Era L Pogosova-Agadjanyan; Amelia Peterson; Jennifer Noteboom; Kathy C O'Briant; April Allen; Daniel W Lin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Derek L Stirewalt; Robert Gentleman; Robert L Vessella; Peter S Nelson; Daniel B Martin; Muneesh Tewari Journal: Proc Natl Acad Sci U S A Date: 2008-07-28 Impact factor: 11.205
Authors: Juan Lu; Qi-Hui Liu; Fan Wang; Jia-Jie Tan; Yue-Qin Deng; Xiao-Hong Peng; Xiong Liu; Bao Zhang; Xia Xu; Xiang-Ping Li Journal: J Exp Clin Cancer Res Date: 2018-07-13
Authors: Mario Dioguardi; Stefania Cantore; Diego Sovereto; Lucia La Femina; Giorgia Apollonia Caloro; Francesca Spirito; Salvatore Scacco; Michele Di Cosola; Lorenzo Lo Muzio; Giuseppe Troiano; Andrea Ballini Journal: Life (Basel) Date: 2022-08-19
Authors: Maria Menini; Emanuele De Giovanni; Francesco Bagnasco; Francesca Delucchi; Francesco Pera; Domenico Baldi; Paolo Pesce Journal: J Pers Med Date: 2021-02-04
Authors: Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis Journal: Int J Mol Sci Date: 2022-07-26 Impact factor: 6.208
Authors: Yiran Peng; Shoushan Hu; Kun Zhang; Yuru Wang; Maierdanjiang Rouzi; Dan Zhou; Ran Yang Journal: Cancer Manag Res Date: 2021-06-17 Impact factor: 3.989